English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Feb 10, 2026

FDA flagged key issues early before rejecting Corcept’s hypercortisolism drug

Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat

Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant

Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue

Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron

Patient Daily | Feb 10, 2026

Penn Medicine expands holistic cancer care with Whole Person Care Collaborative

Patient Daily | Feb 10, 2026

Penn Medicine study finds rising use of methadone but calls for wider access

Patient Daily | Feb 10, 2026

Regulating immune response could help protect neurons in Parkinson’s disease

Trending

+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting

  • « First
  • «
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily